-
Mashup Score: 12Evaluation of ILAR and PRINTO classifications for juvenile idiopathic arthritis: oligoarticular JIA vs early-onset ANA-positive JIA - 23 day(s) ago
Clinical Rheumatology – The International League of Associations for Rheumatology (ILAR) juvenile idiopathic arthritis (JIA) classification was revisited by the Pediatric Rheumatology International…
Source: link.springer.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
The FDA has granted rare pediatric disease designation to a type IA prodrug of dexamethasone that targets CD206+ macrophages for the treatment of systemic juvenile idiopathic arthritis flares, according to a press release from PIF Partners. The proprietary investigational therapeutic, currently known as 101-PGC-005 or ‘005 (PIF Partners), is undergoing phase 3 clinical trials across nine
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 9Qualtrics Survey | Qualtrics Experience Management - 9 month(s) ago
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Source: www.qualtrics.manchester.ac.ukCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0Nearly 40% of children with oligoarthritis need no other therapy after steroid injection - 11 month(s) ago
Nearly 40% of children with oligoarticular juvenile idiopathic arthritis treated with intra-articular corticosteroids required no additional therapy, according to data published in Arthritis Research & Therapy.The study aimed to bring clarity to the early stages of oligoarthritis, the most common form of juvenile idiopathic arthritis, when parents are worried about long-term outcomes, Mojca
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 6Qualtrics Survey | Qualtrics Experience Management - 11 month(s) ago
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Source: ncepod.qualtrics.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4New Study Helps Understand Childhood Arthritis Experiences to Improve Care - Arthritis Research Canada - 1 year(s) ago
A study that aimed to understand the experiences of youth with JIA and their parents managing this disease to help improve care.
Source: www.arthritisresearch.caCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4New Study Helps Understand Childhood Arthritis Experiences to Improve Care - Arthritis Research Canada - 1 year(s) ago
A study that aimed to understand the experiences of youth with JIA and their parents managing this disease to help improve care.
Source: www.arthritisresearch.caCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
AbstractObjectives. We aimed to comprehensively analyze the available literature to identify the unmet requirements in transitional programs tailored specifical
Source: academic.oup.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 4Inflammatory Arthritis Research Agenda - 2 year(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Latest Headlines, RheumatologyTweet-
Help @ArthritisFdn and @carrainc better understand unmet needs and knowledge gaps in #JIA! Take this survey by June 9 if you are 18+ with JIA or are a caretaker of someone with JIA. Participation is voluntary and no personal information will be collected. https://t.co/x3KvWkAWso https://t.co/Q6GdouUhhY
-
-
Mashup Score: 0Nature Reviews Rheumatology - Volume 19 Issue 6, June 2023 - 2 year(s) ago
Inspired by the Review on p331.
Source: NatureCategories: Latest Headlines, RheumatologyTweet
How do ILAR & PRINTO classifications impact #JIA diagnosis and treatment? 👉https://t.co/i9aMJHFO7Z ✅Age & ANA positivity (≥1/160) improve consistency in assessing uveitis risk & treatment response ✅One positive ANA test may be enough—no need for repeat testing ✅ Early… https://t.co/Z0xuWQ2gWI https://t.co/vfhnVF1axX